PAPILLONBIO
Live / Applied — Fourth extension granted (statement of use) (as of 30 Sept 2025)
What this means for you
Not registered yet, but its 21 Sept 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97600812
- Mark type
- Stylized text
- Filed
- 21 Sept 2022
- Published for opposition
- 08 Aug 2023
- Attorney of record
- Bobby A. Ghajar
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and medicinal preparations for the treatment of cancer; vaccines for human use
- Class 042 — Scientific and technological services: Development of nanotechnology-based pharmaceutical preparations for cancer delivery platforms; research and development of pharmaceuticals for the treatment of cancer; research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines
Owner
- Papillon Biosciences, Inc., Pasadena, CA, US
- Papillon Biosciences, Inc., Pasadena, CA, US
Prosecution history
- 27 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 08 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Sept 2025 — SOU EXTENSION 4 GRANTED
- 29 Sept 2025 — SOU EXTENSION 4 FILED
- 29 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 01 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Apr 2025 — SOU EXTENSION 3 GRANTED
- 01 Apr 2025 — SOU EXTENSION 3 FILED
- 31 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 27 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Sept 2024 — SOU EXTENSION 2 GRANTED
- 27 Sept 2024 — SOU EXTENSION 2 FILED
- 27 Sept 2024 — SOU TEAS EXTENSION RECEIVED
- 03 Apr 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Apr 2024 — SOU EXTENSION 1 GRANTED